Strata Critical Medical, Inc. - Class A (SRTA) Covered Calls

Strata Critical Medical, Inc. is a leading provider of time-critical logistics and specialized medical services for the healthcare industry. The company operates one of the largest air and ground transport networks in the United States dedicated to the organ transplant sector. Through its integrated "one-call" solution, it provides organ recovery, surgical perfusion, and clinical staffing services, ensuring the reliable and efficient delivery of life-saving medical resources.

You can sell covered calls on Strata Critical Medical, Inc. - Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SRTA (prices last updated Tue 4:16 PM ET):

Strata Critical Medical, Inc. - Class A (SRTA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.20 -0.12 4.16 4.29 659K 8.8 0.4
Covered Calls For Strata Critical Medical, Inc. - Class A (SRTA)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Mar 20 5 0.00 4.29 0.0% 0.0%
Apr 17 5 0.15 4.14 3.6% 24.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Strata Critical Medical, Inc. (SRTA) is a specialized healthcare logistics firm that focuses on the macro-non-correlated market for organ transplant services. Following its divestiture of its passenger flight division in 2025, the company shifted its entire focus to its medical brand, which serves organ procurement organizations and transplant centers across the country. Its subsidiary, Trinity Medical Solutions, is a core component of this platform, providing the technical and logistical infrastructure needed to move human organs and surgical teams with extreme precision.

The company operates a vertically integrated model that combines transportation with high-level clinical services. This includes Normothermic Regional Perfusion (NRP), which is a sophisticated technique used to preserve organ function during the recovery process. By offering an end-to-end service—from organ placement and surgical recovery to final delivery—the company significantly reduces the logistical burden on hospitals. This integrated approach is critical for the transplant industry, where the timing and quality of transport directly impact patient outcomes.

Competitive Landscape

The competitive landscape for Strata Critical Medical involves specialized medical transport firms and broader healthcare service providers. Primary rivals that are publicly traded on the NYSE or NASDAQ and offer optionable stocks include Wheels Up Experience and Skyward Specialty Insurance (as a provider of related risk management). While many air mobility firms are moving toward passenger eVTOL applications, Strata’s pivot has placed it in direct competition with specialized healthcare services firms such as Cross Country Healthcare and Option Care Health.

Other notable competitors in the aviation and medical infrastructure sectors with active options trading include Joby Aviation, which purchased the company former passenger business and remains a strategic partner. Strata distinguishes itself through its dominant market share in the transplant niche and its "asset-light" logistics model, which allows it to scale capacity without the heavy overhead of owning a massive fleet of aircraft. This focus on mission-critical medical services provides a more stable, contractual revenue stream compared to traditional discretionary travel providers.

Strategic Outlook

Strategic innovation is focused on the expansion of the "One Call" clinical platform and the integration of new organ preservation technologies. The company is investing in advanced perfusion equipment and specialized surgical staffing to support the rising demand for DCD (Donation after Circulatory Death) transplants. These efforts are designed to increase the number of transplantable organs available, thereby expanding the company addressable market and improving its overall clinical service margins.

The outlook involves a continued "roll-up" strategy, targeting regional medical logistics providers to consolidate the fragmented transplant services market. Management is prioritizing the development of long-term, high-margin contracts with major hospital networks and exploring adjacent medical logistics opportunities, such as the transport of radiopharmaceuticals. By maintaining a strong balance sheet and leveraging its strategic partnership with Joby Aviation for future zero-emission medical flights, the company aims to solidify its position as the premier infrastructure provider for the nation healthcare system.